Klaria Pharma Holding AB (publ.) (FRA:6FN)
Germany flag Germany · Delayed Price · Currency is EUR
0.0648
-0.0016 (-2.41%)
Feb 20, 2026, 4:00 PM EST

FRA:6FN Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
181544631
Market Cap Growth
36.27%257.66%-4.38%-28.15%-80.18%-4.09%
Enterprise Value
181544629
Last Close Price
0.060.070.020.030.080.54
PS Ratio
21.0918.2321.575.8211.7052.30
PB Ratio
-48.84-42.2314.671.200.904.61
EV/Sales Ratio
20.8418.0221.335.5510.7048.07
Debt / Equity Ratio
-0.16-0.167.390.490.240.46
Net Debt / Equity Ratio
-0.07-0.077.210.460.020.09
Net Debt / EBITDA Ratio
-0.02-0.02-1.19-0.88-0.03-0.09
Net Debt / FCF Ratio
-0.01-0.01-2.00-2.06-0.03-0.25
Asset Turnover
0.180.180.040.090.050.05
Quick Ratio
0.050.050.040.100.470.57
Current Ratio
0.050.050.050.140.930.58
Return on Equity (ROE)
---214.91%-61.06%-87.66%-59.81%
Return on Assets (ROA)
-32.18%-32.18%-30.03%-20.82%-29.05%-40.37%
Return on Capital Employed (ROCE)
773.70%773.70%-797.70%-78.20%-72.50%-115.00%
Earnings Yield
-20.52%-23.74%-98.47%-72.73%-92.92%-16.75%
FCF Yield
--21.39%-24.55%-18.41%-72.52%-7.76%
Buyback Yield / Dilution
-49.19%-49.19%-25.62%-73.49%-12.15%-19.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.